ImGettingBetter
Thanks for your reply and I am aware of what they are doing now to enhance a Re-Exam with new CHMP people as replacements for this!
Not quite sure how or if the rapporteurs from the EMA would be replaced though; certainly I would hope that the 30 new CHMP participants would also be screened since they have 60 people to sort this out.
I recognize that the data given fell short within the current group even though the rapporteurs apparently accepted what they originally had as good enough during discussions.
My hope is for a RAPID effort on the part of Anavex to get Big Pharma help (we should expect that they would want a bigger piece of the pie); moving on an FDA filing would have been expected after EMA approval, but now it's vital to file early with this new data we have, yet risky.
Let's hope that Missling realizes any option grants now should be ZERO because of this failure....many of his High Strikes will most probably never be worthwhile....some of the lower strikes might be.....
I think my tax gains vs this loss will not be a problem...my cost basis on $COST was less than $400, sold at $940........so this year will be very profitable even with the loss in $AVXL....
Steve
Market Data 
Markets 
AI
